| Inverness Medical Innovations Declares Dividend on Its Series B Convertible Perpetual Preferred Stock (PR Newswire) Inverness Medical Innovations, Inc. , a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock . Â The dividend will be paid in shares of Series B stock in an amount per share equal to the quotient of $3.00 divided by 97% of the average of the volume-weighted average price per share of the Series B stock on the New York Stock Exchange for each of the five consecutive trading days ending on the second trading day immediately prior to the record date of the dividend. Â Inverness will pay cash in lieu of any fractional shares resulting from the dividend. Â The dividend is payable on July 15, 2010 to holders of record of Series B stock at the close of business on July 1, 2010. Â us.rd.yahoo.com |
Lactobacillus reuteri Protectis Reduced Crying Time in Infants With Colic - Video New study presented: Lactobacillus reuteri Protectis Reduced Crying Time in Infants With Colic feedproxy.google.com |
Theragenics Corporation Q2 2010 Earnings Call Transcript Theragenics Corporation (TGX)Q2 2010 Earnings Call TranscriptAugust 10, 2010 11:00 am ETComplete Story » seekingalpha.com |
Why Trainers Say, 'Slow Down' Research shows injury rates rise as runners increase their weekly mileage. Personal trainers and coaches are now helping Type-A runners realize their limits. online.wsj.com |
FDA Warns Mead Johnson on Enfamil Packaging The FDA warned Mead Johnson about the packaging for some of the company's Enfamil infant formulas. online.wsj.com |